{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:51:50Z","timestamp":1791165110389,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor metastasis is a leading cause of patient mortality, with tumor dissemination and organotropism representing critical yet complex aspects of tumor biology that involve clonal selection and evolutionary dynamics. Current experimental models inadequately recapitulate the spatiotemporal dissemination and phenotypic heterogeneity of human cancers, highlighting a critical need for more physiologically relevant preclinical platforms. In this study, we utilized a kidney-tropic primary extranodal lymphoma model to explore the role of EFNB1 in lymphoma dissemination across two distinct mouse strains, C57BL\/6J and C57BL\/10J. Intriguingly, EFNB1-overexpressing lymphoma cells displayed markedly different progression rates and colonization patterns in these strains. EFNB1-null and EFNB1-high lymphomas derived from the two strains underwent distinct clonal selection and exhibited significant transcriptomic heterogeneity, including RNA base substitutions, as well as differential expression of nuclear histone genes and mitochondrial respiratory chain genes. Notably, clonal origin alone did not determine lymphoma organotropism. Collectively, this study establishes a readily reproducible extranodal lymphoma model and demonstrates that host heterogeneity can reshape transcriptional heterogeneity, drive tumor clonal selection, and ultimately dictate organotropism. These findings suggest that host heterogeneity may serve as a valuable prognostic indicator for lymphoma.<\/jats:p>","DOI":"10.1038\/s41419-026-09014-3","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:46:29Z","timestamp":1783655189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Host heterogeneity shapes clonal selection and organotropism in an extranodal lymphoma mouse model"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5399-5628","authenticated-orcid":false,"given":"Xiaoxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4450-6110","authenticated-orcid":false,"given":"Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7006-3381","authenticated-orcid":false,"given":"Chuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"9014_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021;384:842\u201358.","journal-title":"N Engl J Med"},{"key":"9014_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s43556-023-00141-3","volume":"4","author":"H Yang","year":"2023","unstructured":"Yang H, Xun Y, Ke C, Tateishi K, You H. Extranodal lymphoma: pathogenesis, diagnosis and treatment. Mol Biomed. 2023;4:29.","journal-title":"Mol Biomed"},{"key":"9014_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37:551\u201368.e14.","journal-title":"Cancer Cell"},{"key":"9014_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cell.2020.05.049","volume":"182","author":"L Venturutti","year":"2020","unstructured":"Venturutti L, Teater M, Zhai A, Chadburn A, Babiker L, Kim D, et al. TBL1XR1 mutations drive extranodal lymphoma by inducing a pro-tumorigenic memory fate. Cell. 2020;182:297\u2013316.e27.","journal-title":"Cell"},{"key":"9014_CR5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1182\/blood.2022016943","volume":"141","author":"L Delage","year":"2023","unstructured":"Delage L, Lambert M, Bardel \u00c9, Kundlacz C, Chartoire D, Conchon A, et al. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1. Blood. 2023;141:1209\u201320.","journal-title":"Blood"},{"key":"9014_CR6","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.cell.2023.02.026","volume":"186","author":"L Wakefield","year":"2023","unstructured":"Wakefield L, Agarwal S, Tanner K. Preclinical models for drug discovery for metastatic disease. Cell. 2023;186:1792\u2013813.","journal-title":"Cell"},{"key":"9014_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2927","volume":"13","author":"EJ Kim","year":"2011","unstructured":"Kim EJ, Choi M-R, Park H, Kim M, Hong JE, Lee J-Y, et al. Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB\/c mice. Breast Cancer Res. 2011;13:R78.","journal-title":"Breast Cancer Res"},{"key":"9014_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3389\/fonc.2019.00685","volume":"9","author":"GCM Evangelista","year":"2019","unstructured":"Evangelista GCM, Salvador PA, Soares SMA, Barros LRC, Xavier FHdaC, Abdo LM, et al. 4T1 mammary carcinoma colonization of metastatic niches is accelerated by obesity. Front Oncol. 2019;9:685.","journal-title":"Front Oncol"},{"key":"9014_CR9","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1101\/gad.13.20.2670","volume":"13","author":"CA Schmitt","year":"1999","unstructured":"Schmitt CA, McCurrach ME, Stanchina E, de, Wallace-Brodeur RR, Lowe SW. INK4a\/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 1999;13:2670\u20137.","journal-title":"Genes Dev"},{"key":"9014_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1089187","volume":"13","author":"X Li","year":"2023","unstructured":"Li X, Deng M, Zhang C, Luo L, Qian H. Establishment of a primary renal lymphoma model and its clinical relevance. Front Oncol. 2023;13:1089187.","journal-title":"Front Oncol"},{"key":"9014_CR11","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1177\/0300060519842049","volume":"47","author":"X Cheng","year":"2019","unstructured":"Cheng X, Huang Z, Li D, Wang Y. Enormous primary renal diffuse large B-cell lymphoma: a case report and literature review. J Int Med Res. 2019;47:2728\u201339.","journal-title":"J Int Med Res"},{"key":"9014_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1084\/jem.20161461","volume":"214","author":"BJ Laidlaw","year":"2017","unstructured":"Laidlaw BJ, Schmidt TH, Green JA, Allen CDC, Okada T, Cyster JG. The Eph-related tyrosine kinase ligand Ephrin-B1 marks germinal center and memory precursor B cells. J Exp Med. 2017;214:639\u201349.","journal-title":"J Exp Med"},{"key":"9014_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aai9264","volume":"356","author":"P Lu","year":"2017","unstructured":"Lu P, Shih C, Qi H. Ephrin B1-mediated repulsion and signaling control germinal center T cell territoriality and function. Science. 2017;356:eaai9264.","journal-title":"Science"},{"key":"9014_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05084-w","volume":"9","author":"X Li","year":"2018","unstructured":"Li X, Zhang Y, Zheng L, Liu M, Chen CD, Jiang H. UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma. Nat Commun. 2018;9:2720.","journal-title":"Nat Commun"},{"key":"9014_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108667","volume":"27","author":"X Li","year":"2024","unstructured":"Li X, Zhang C, Deng M, Jiang Y, He Z, Qian H. EFNB1 levels determine distinct drug response patterns guiding precision therapy for B-cell neoplasms. iScience. 2024;27:108667.","journal-title":"iScience"},{"key":"9014_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108229","volume":"301","author":"X Li","year":"2025","unstructured":"Li X, Jiang Y, Deng M, Zhang C, Tang H. N-glycosylation of ephrin B1 modulates its function and confers therapeutic potential in B-cell lymphoma. J Biol Chem. 2025;301:108229.","journal-title":"J Biol Chem"},{"key":"9014_CR17","doi-asserted-by":"crossref","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinform. 2013;43:11.10.1\u201311.10.33.","journal-title":"Curr Protoc Bioinform"},{"key":"9014_CR18","doi-asserted-by":"publisher","first-page":"W514","DOI":"10.1093\/nar\/gkx367","volume":"45","author":"A Goncearenco","year":"2017","unstructured":"Goncearenco A, Rager SL, Li M, Sang Q-X, Rogozin IB, Panchenko AR. Exploring background mutational processes to decipher cancer genetic heterogeneity. Nucleic Acids Res. 2017;45:W514\u201322.","journal-title":"Nucleic Acids Res"},{"key":"9014_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-191","volume":"7","author":"J Ernst","year":"2006","unstructured":"Ernst J, Bar-Joseph Z. STEM: a tool for the analysis of short time series gene expression data. BMC Bioinform. 2006;7:191.","journal-title":"BMC Bioinform"},{"key":"9014_CR20","doi-asserted-by":"publisher","first-page":"e74250","DOI":"10.1371\/journal.pone.0074250","volume":"8","author":"R Aguirre-Gamboa","year":"2013","unstructured":"Aguirre-Gamboa R, Gomez-Rueda H, Mart\u00ednez-Ledesma E, Mart\u00ednez-Torteya A, Chacolla-Huaringa R, Rodriguez-Barrientos A, et al. SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS ONE. 2013;8:e74250.","journal-title":"PLoS ONE"},{"key":"9014_CR21","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"G Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008;359:2313\u201323.","journal-title":"N Engl J Med"},{"key":"9014_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1182\/bloodadvances.2018020602","volume":"3","author":"R McCord","year":"2019","unstructured":"McCord R, Bolen CR, Koeppen H, Kadel EE, Oestergaard MZ, Nielsen T, et al. PD-L1 and tumor-associated macrophages in de novo DLBCL. Blood Adv. 2019;3:531\u201340.","journal-title":"Blood Adv"},{"key":"9014_CR23","doi-asserted-by":"publisher","first-page":"D923","DOI":"10.1093\/nar\/gky872","volume":"47","author":"D van der Meer","year":"2019","unstructured":"van der Meer D, Barthorpe S, Yang W, Lightfoot H, Hall C, Gilbert J, et al. Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models. Nucleic Acids Res. 2019;47:D923\u20139.","journal-title":"Nucleic Acids Res"},{"key":"9014_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/cells12010037","volume":"12","author":"R Winkler","year":"2023","unstructured":"Winkler R, Piskor E-M, Kosan C. Lessons from using genetically engineered mouse models of MYC-induced lymphoma. Cells. 2023;12:37.","journal-title":"Cells"},{"key":"9014_CR25","doi-asserted-by":"publisher","first-page":"a034827","DOI":"10.1101\/cshperspect.a034827","volume":"11","author":"L Pasqualucci","year":"2021","unstructured":"Pasqualucci L, Klein U. Mouse models in the study of mature B-cell malignancies. Cold Spring Harb Perspect Med. 2021;11:a034827.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9014_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nri953","volume":"2","author":"AL Shaffer","year":"2002","unstructured":"Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol. 2002;2:920\u201332.","journal-title":"Nat Rev Immunol"},{"key":"9014_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985;318:533\u20138.","journal-title":"Nature"},{"key":"9014_CR28","doi-asserted-by":"publisher","first-page":"8525","DOI":"10.1158\/0008-5472.CAN-08-1329","volume":"68","author":"S Mori","year":"2008","unstructured":"Mori S, Rempel RE, Chang JT, Yao G, Lagoo AS, Potti A, et al. Utilization of pathway signatures to reveal distinct types of B lymphoma in the E\u03bc-myc Model and human diffuse large B-cell lymphoma. Cancer Res. 2008;68:8525\u201334.","journal-title":"Cancer Res"},{"key":"9014_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68:820\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9014_CR30","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","volume":"13","author":"CM Eischen","year":"1999","unstructured":"Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF\u2013Mdm2\u2013p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 1999;13:2658\u201369.","journal-title":"Genes Dev"},{"key":"9014_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14581","volume":"8","author":"M Lefebure","year":"2017","unstructured":"Lefebure M, Tothill RW, Kruse E, Hawkins ED, Shortt J, Matthews GM, et al. Genomic characterisation of E\u03bc-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene. Nat Commun. 2017;8:14581.","journal-title":"Nat Commun"},{"key":"9014_CR32","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1182\/blood-2010-10-313098","volume":"118","author":"C Schuster","year":"2011","unstructured":"Schuster C, Berger A, Hoelzl MA, Putz EM, Frenzel A, Simma O, et al. The cooperating mutation or \u2018second hit\u2019 determines the immunologic visibility toward MYC-induced murine lymphomas. Blood. 2011;118:4635\u201345.","journal-title":"Blood"},{"key":"9014_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1024-y","volume":"17","author":"AG Doran","year":"2016","unstructured":"Doran AG, Wong K, Flint J, Adams DJ, Hunter KW, Keane TM. Deep genome sequencing and variation analysis of 13 inbred mouse strains defines candidate phenotypic alleles, private variation and homozygous truncating mutations. Genome Biol. 2016;17:167.","journal-title":"Genome Biol"},{"key":"9014_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100102","volume":"2","author":"M Mortazavi","year":"2022","unstructured":"Mortazavi M, Ren Y, Saini S, Antaki D, St. Pierre CL, Williams A, et al. SNPs, short tandem repeats, and structural variants are responsible for differential gene expression across C57BL\/6 and C57BL\/10 substrains. Cell Genom. 2022;2:100102.","journal-title":"Cell Genom"},{"key":"9014_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccell.2021.11.004","volume":"40","author":"CA Grzelak","year":"2022","unstructured":"Grzelak CA, Goddard ET, Lederer EE, Rajaram K, Dai J, Shor RE, et al. Elimination of fluorescent protein immunogenicity permits modeling of metastasis in immune-competent settings. Cancer Cell. 2022;40:1\u20132.","journal-title":"Cancer Cell"},{"key":"9014_CR36","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41586-020-03147-x","volume":"590","author":"D Alonso-Curbelo","year":"2021","unstructured":"Alonso-Curbelo D, Ho Y-J, Burdziak C, Maag JLV, Morris JP, Chandwani R, et al. A gene-environment-induced epigenetic program initiates tumorigenesis. Nature. 2021;590:642\u20138.","journal-title":"Nature"},{"key":"9014_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/PAP.0000000000000127","volume":"23","author":"JL Dy-Ledesma","year":"2016","unstructured":"Dy-Ledesma JL, Khoury JD, Agbay RLMC, Garcia M, Miranda RN, Medeiros LJ. Starry sky pattern in hematopoietic neoplasms: a review of pathophysiology and differential diagnosis. Adv Anat Pathol. 2016;23:343\u201355.","journal-title":"Adv Anat Pathol"},{"key":"9014_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1080626","volume":"10","author":"R Pecori","year":"2022","unstructured":"Pecori R, Chill\u00f3n I, Lo Giudice C, Arnold A, W\u00fcst S, Binder M, et al. ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts. Front Cell Dev Biol. 2022;10:1080626.","journal-title":"Front Cell Dev Biol"},{"key":"9014_CR39","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1101\/gr.246033.118","volume":"29","author":"T-L Mai","year":"2019","unstructured":"Mai T-L, Chuang T-J. A-to-I RNA editing contributes to the persistence of predicted damaging mutations in populations. Genome Res. 2019;29:1766\u201376.","journal-title":"Genome Res"},{"key":"9014_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1638-y","volume":"20","author":"NA An","year":"2019","unstructured":"An NA, Ding W, Yang X-Z, Peng J, He BZ, Shen QS, et al. Evolutionarily significant A-to-I RNA editing events originated through G-to-A mutations in primates. Genome Biol. 2019;20:24.","journal-title":"Genome Biol"},{"key":"9014_CR41","doi-asserted-by":"publisher","unstructured":"Pecori R, Ren W, Pirmoradian M, Wang X, Liu D, Berglund M, et al. ADAR1-mediated RNA editing promotes B cell lymphomagenesis. iScience. 2023;26. https:\/\/doi.org\/10.1016\/j.isci.2023.106864.","DOI":"10.1016\/j.isci.2023.106864"},{"key":"9014_CR42","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.celrep.2013.10.002","volume":"5","author":"IX Wang","year":"2013","unstructured":"Wang IX, So E, Devlin JL, Zhao Y, Wu M, Cheung VG. ADAR regulates RNA editing, transcript stability, and gene expression. Cell Rep. 2013;5:849\u201360.","journal-title":"Cell Rep"},{"key":"9014_CR43","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41375-020-0995-6","volume":"35","author":"FJ Gassner","year":"2021","unstructured":"Gassner FJ, Zaborsky N, Buchumenski I, Levanon EY, Gatterbauer M, Schubert M, et al. RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia. Leukemia. 2021;35:1053\u201363.","journal-title":"Leukemia"},{"key":"9014_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41576-018-0006-1","volume":"19","author":"E Eisenberg","year":"2018","unstructured":"Eisenberg E, Levanon EY. A-to-I RNA editing - immune protector and transcriptome diversifier. Nat Rev Genet. 2018;19:473\u201390.","journal-title":"Nat Rev Genet"},{"key":"9014_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrc4044","volume":"15","author":"L Shipman","year":"2015","unstructured":"Shipman L. Cancer genomics: The relevance of extensive editing in tumour transcriptomes. Nat Rev Cancer. 2015;15:698.","journal-title":"Nat Rev Cancer"},{"key":"9014_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.celrep.2015.08.080","volume":"13","author":"N Paz-Yaacov","year":"2015","unstructured":"Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, et al. Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep. 2015;13:267\u201376.","journal-title":"Cell Rep"},{"key":"9014_CR47","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","volume":"123","author":"DW Scott","year":"2014","unstructured":"Scott DW, Wright GW, Williams PM, Lih C-J, Walsh W, Jaffe ES, et al. Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. Blood. 2014;123:1214\u20137.","journal-title":"Blood"},{"key":"9014_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017;171:481\u201394.e15.","journal-title":"Cell"},{"key":"9014_CR49","doi-asserted-by":"publisher","unstructured":"Li X, Jiang Y, Qian H. Lymphoma dissemination is a pathological hallmark for malignant progression of B-cell lymphoma. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1286411.","DOI":"10.3389\/fimmu.2023.1286411"},{"key":"9014_CR50","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tcb.2017.02.004","volume":"27","author":"O Matilainen","year":"2017","unstructured":"Matilainen O, Quir\u00f3s PM, Auwerx J. Mitochondria and epigenetics\u2014crosstalk in homeostasis and stress. Trends Cell Biol. 2017;27:453\u201363.","journal-title":"Trends Cell Biol"},{"key":"9014_CR51","doi-asserted-by":"publisher","first-page":"101806","DOI":"10.1016\/j.gendis.2025.101806","volume":"13","author":"C Huang","year":"2026","unstructured":"Huang C, Xie Z, Li J, Zhang C. Mitochondria and tumorigenesis: molecular basis and therapeutic implications. Genes Dis. 2026;13:101806.","journal-title":"Genes Dis"},{"key":"9014_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.tcb.2021.07.003","volume":"31","author":"W Hill","year":"2021","unstructured":"Hill W, Caswell DR, Swanton C. Capturing cancer evolution using genetically engineered mouse models (GEMMs). Trends Cell Biol. 2021;31:1007\u201318.","journal-title":"Trends Cell Biol"},{"key":"9014_CR53","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, Bernard E, Abbosh C, Andr\u00e9 F, Auwerx J, Balmain A, et al. Embracing cancer complexity: hallmarks of systemic disease. Cell. 2024;187:1589\u2013616.","journal-title":"Cell"},{"key":"9014_CR54","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrg2438","volume":"9","author":"WF Marzluff","year":"2008","unstructured":"Marzluff WF, Wagner EJ, Duronio RJ. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat Rev Genet. 2008;9:843\u201354.","journal-title":"Nat Rev Genet"},{"key":"9014_CR55","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1093\/nar\/gkw418","volume":"44","author":"SM Lyons","year":"2016","unstructured":"Lyons SM, Cunningham CH, Welch JD, Groh B, Guo AY, Wei B, et al. A subset of replication-dependent histone mRNAs are expressed as polyadenylated RNAs in terminally differentiated tissues. Nucleic Acids Res. 2016;44:9190\u2013205.","journal-title":"Nucleic Acids Res"},{"key":"9014_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01057-x","volume":"13","author":"S Amatori","year":"2021","unstructured":"Amatori S, Tavolaro S, Gambardella S, Fanelli M. The dark side of histones: genomic organization and role of oncohistones in cancer. Clin Epigenetics. 2021;13:71.","journal-title":"Clin Epigenetics"},{"key":"9014_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16472-5","volume":"7","author":"X Li","year":"2017","unstructured":"Li X, Tian R, Gao H, Yang Y, Williams BRG, Gantier MP, et al. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients. Sci Rep. 2017;7:16495.","journal-title":"Sci Rep"},{"key":"9014_CR58","first-page":"4893","volume":"18","author":"W Xie","year":"2019","unstructured":"Xie W, Zhang J, Zhong P, Qin S, Zhang H, Fan X, et al. Expression and potential prognostic value of histone family gene signature in breast cancer. Exp Ther Med. 2019;18:4893\u2013903.","journal-title":"Exp Ther Med"},{"key":"9014_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.816939","volume":"9","author":"J Zhou","year":"2022","unstructured":"Zhou J, Xing Z, Xiao Y, Li M, Li X, Wang D, et al. The value of H2BC12 for predicting poor survival outcomes in patients with WHO Grade II and III gliomas. Front Mol Biosci. 2022;9:816939.","journal-title":"Front Mol Biosci"},{"key":"9014_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.966817","volume":"12","author":"J Jia","year":"2022","unstructured":"Jia J, Han Z, Wang X, Zheng X, Wang S, Cui Y. H2B gene family: a prognostic biomarker and correlates with immune infiltration in glioma. Front Oncol. 2022;12:966817.","journal-title":"Front Oncol"},{"key":"9014_CR61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-020-3017-y","volume":"589","author":"N Yusufova","year":"2021","unstructured":"Yusufova N, Kloetgen A, Teater M, Osunsade A, Camarillo JM, Chin CR, et al. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature. 2021;589:299\u2013305.","journal-title":"Nature"},{"key":"9014_CR62","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1158\/0008-5472.CAN-21-2619","volume":"81","author":"AA Soshnev","year":"2021","unstructured":"Soshnev AA, Allis CD, Cesarman E, Melnick AM. Histone H1 mutations in lymphoma: a link(er) between chromatin organization, developmental reprogramming, and cancer. Cancer Res. 2021;81:6061\u201370.","journal-title":"Cancer Res"},{"key":"9014_CR63","doi-asserted-by":"publisher","unstructured":"Mahmood M, Liu EM, Shergold AL, Tolla E, Tait-Mulder J, Huerta-Uribe A, et al. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma. Nat Cancer. 2024. https:\/\/doi.org\/10.1038\/s43018-023-00721-w.","DOI":"10.1038\/s43018-023-00721-w"},{"key":"9014_CR64","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s42003-022-03846-3","volume":"5","author":"C Bruhn","year":"2022","unstructured":"Bruhn C, Bastianello G, Foiani M. Cancer cell histone density links global histone acetylation, mitochondrial proteome and histone acetylase inhibitor sensitivity. Commun Biol. 2022;5:882.","journal-title":"Commun Biol"},{"key":"9014_CR65","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/nbdi.1996.0020","volume":"3","author":"GM Pasinetti","year":"1996","unstructured":"Pasinetti GM, Tocco G, Sakhi S, Musleh WD, DeSimoni MG, Mascarucci P, et al. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol Dis. 1996;3:197\u2013204.","journal-title":"Neurobiol Dis"},{"key":"9014_CR66","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2337\/db06-0358","volume":"55","author":"HC Freeman","year":"2006","unstructured":"Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD. Deletion of nicotinamide nucleotide transhydrogenase: a new quantitative trait locus accounting for glucose intolerance in C57BL\/6J mice. Diabetes. 2006;55:2153\u20136.","journal-title":"Diabetes"},{"key":"9014_CR67","doi-asserted-by":"publisher","unstructured":"Li X, Luo L, Qian H. Improving the predictive accuracy of efficacy evaluation using tumor orthotopic transplant and resection model. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1309876.","DOI":"10.3389\/fphar.2024.1309876"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09014-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:02:44Z","timestamp":1791162164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09014-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9014"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09014-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"XL, MD, and HT are listed as inventors on a Chinese patent application (CN-ZL2022103712248) related to the MAB1 cell strain in this manuscript. XL, HT, and ZW are co-founders of MD BioMedTech Co., Ltd. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experimental procedures were conducted in accordance with relevant institutional guidelines and regulations. All animal procedures performed in this study were reviewed and approved by the Animal Care and Use Committee of Laboratory Animal Research Center, Jiangsu University (Approval No.: UJS-IACUC-2023063001).","order":2,"name":"Ethics","label":"Ethics declarations","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"856"}}